Related Experiment Video

Updated: Jun 22, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation

Lei Wang1, Xi-Xi Cao, Qi Chen

  • 1Department of Pathology, Shanghai Medical School, Research Center for Pathology, Institute of Biomedical Science, Fudan University, Shanghai, China.

Cancer Science
|July 4, 2009
PubMed

Insights

DIXDC1 protein, a Wnt signaling regulator, is upregulated in colon cancer, promoting cell proliferation and tumor growth. Targeting DIXDC1 may offer new therapeutic strategies for colorectal adenocarcinoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • DIXDC1 (DIX domain containing 1) is a positive regulator of the Wnt signaling pathway.
  • Wnt pathway activation is linked to colon cancer development and progression.

Purpose of the Study:

  • To investigate the role of DIXDC1 in human colorectal adenocarcinoma.
  • To elucidate the molecular mechanisms by which DIXDC1 influences colon cancer cell proliferation and tumorigenesis.

Main Methods:

  • Analysis of DIXDC1 protein levels in human colorectal adenocarcinoma tissues.
  • In vitro and in vivo studies involving ectopic DIXDC1 overexpression and siRNA knockdown.
  • Cell cycle analysis and Western blotting to assess protein expression (cyclin D1, p21).
  • Investigation of the PI3K/AKT pathway activation.

Main Results:

  • DIXDC1 protein was upregulated in colorectal adenocarcinoma tissues and correlated with high cell proliferation.
  • Overexpression of DIXDC1 increased colon cancer cell proliferation in vitro and accelerated tumor growth in vivo.
  • DIXDC1 promoted cell cycle progression (G0/G1 to S phase) by upregulating cyclin D1 and downregulating p21.
  • DIXDC1 activated the PI3K/AKT pathway, and inhibiting this pathway reversed DIXDC1-induced effects on cell cycle and protein expression.

Conclusions:

  • Overexpression of DIXDC1 contributes to colon cancer cell proliferation and tumorigenesis.
  • DIXDC1 likely targets p21 and cyclin D1 to promote cancer progression, at least partially via PI3K/AKT pathway activation.
  • DIXDC1 represents a potential therapeutic target for colorectal cancer.

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...